Table 2.
Tumor response.
| Cohort 1A | Cohort 1B | Cohort 2 | |
|---|---|---|---|
| n = 8 | n = 9 | n = 8 | |
| Best overall response, n (%) | |||
| Complete response | 1 (12.5) | 2 (22.2) | 3 (37.5) |
| Partial response | 5 (62.5) | 2 (22.2) | 2 (25.0) |
| Stable disease | 1 (12.5) | 2 (22.2) | 0 (0.0) |
| Progressive disease | 0 (0.0) | 2 (22.2) | 1 (12.5) |
| Not evaluable | 1 (12.5) | 1 (11.1) | 2 (25.0) |
| Confirmed ORR, % (95% CI) | 75.0 (34.9–96.8) | 44.4 (13.7–78.8) | 62.5 (24.5–91.5) |
| Confirmed DCR, % (95% CI) | 87.5 (47.3–99.7) | 66.7 (29.9–92.5) | 62.5 (24.5–91.5) |
| Median DOR, % (95% CI) | 7.4 (4.2–NR) | NR (10.4–NR) | NR (NR–NR) |
Abbreviations: CI, confidence interval; DCR, disease control rate; DOR, duration of response; NR, not reached; ORR, objective response rate.